
Fluence Pharma
About Fluence Pharma
Fluence Pharma is a Healthcare company based in Mumbai (India), and was acquired by Honasa Consumer in June 2026. It develops and manufactures personalized nutritional supplements for health and wellness. It operates on a B2B model. Its Indian entity Fluence Pharma Private Limited reported revenue of βΉ37.55 Cr. Its focus areas include Pharmaceuticals, Nutritional Supplements and Personalized Products. Its competitors include Mamaearth, MyGlamm and WOW Skin Science; 3 of its 3 listed competitors have raised funding.
Company details
Fluence Pharma, based in Mumbai, focuses on providing healthcare solutions, producing pharmaceutical products, nutritional supplements, and personalized products. Develops and manufactures personalized nutritional supplements for health and wellness. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Mumbai, India
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website fluencepharma.in
- Social LinkedIn Facebook Instagram
- Acquired by Honasa Consumer (Jun 2026)
- Legal Name Fluence Pharma Private Limited
- Date of Incorporation 05 Mar, 2012
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹37.55 Cr
FY 2025 · +4% YoY
- Net Profit₹9.00 Cr
FY 2025 · 24% margin
- EBITDA₹12.99 Cr
FY 2025 · 35% margin
- Investors
- Acquired byHonasa Consumer
(Jun 2026)
Associated legal entities of Fluence Pharma
Fluence Pharma operates through Fluence Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Fluence Pharma Private Limited CIN U24233MH2012PTC227677 | Active | 05 Mar 2012 | Mumbai, Maharashtra | ₹37.6 Cr | 11 | 3 | View details |
Investors in Fluence Pharma
Fluence Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Honasa Consumer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Online beauty brand offering multi-category products | 2016 | honasa.in | Gurugram, India |
Investor details for Fluence Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Fluence Pharma Private Limited (Fluence Pharma)
Fluence Pharma Private Limited is the primary company behind Fluence Pharma. The board of Fluence Pharma Private Limited currently have 3 directors; the longest-serving is Ashokkumar Bhusari, appointed in 2012. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashokkumar Bhusari DIN 02502928 | Director | 05 Mar 2012 | 14 yrs 7 mo | Fluence Pharma Private Limited |
| Rajendrasingh Jalamsingh Rajput DIN 00414311 | Director | 18 Feb 2022 | 4 yrs 8 mo | Fluence Pharma Private Limited |
| Abhijit Paul DIN 02897939 | Director | 18 Feb 2022 | 4 yrs 8 mo | Fluence Pharma Private Limited |
Financials of Fluence Pharma
Figures of Fluence Pharma Private Limited, the primary company behind Fluence Pharma, for FY 2025. Revenue was ₹37.55 Cr (+4% year on year). Net profit was ₹9.00 Cr (24% margin). EBITDA was ₹12.99 Cr (35% margin). Revenue has grown at a compounded annual rate of +10% over three years and +25% over five years.
- ₹37.55 CrRevenue · FY 2025 · +4% YoY
- ₹9.00 CrNet profit · 24% margin
- ₹12.99 CrEBITDA · 35% margin
- ₹1 LakhPaid-up capital
- 11Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +25%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Fluence Pharma Private Limited are on its company page.
Detailed financial statements for Fluence Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Fluence Pharma
Fluence Pharma has 3 listed competitors in our database, 3 of them funded. They include Mamaearth, MyGlamm and WOW Skin Science.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mamaearth.in | 2016 | Gurugram, India | $89.36M | 1,900 | Online brand offering multi-category natural skin care and makeup products | |
| myglamm.com | 2015 | Mumbai, India | $105.68M | 411 | Online platform selling beauty products, makeup, skincare, and cosmetics in India. | |
| buywow.in | 2014 | Bengaluru, India | $98M | 100 | Organic beauty products are offered by an internet-first brand. |
Detailed competitors of Fluence Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Fluence Pharma
The website of Fluence Pharma (fluencepharma.in) receives about 9.3K visits a month.
- Monthly visits9.3K
▼ 39.1% vs previous month
Top companies in Alternative Medicine Products
3 companies that operate in the same segment as Fluence Pharma (Alternative Medicine Products) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Homeopathic medicine manufacturing and online retail in India. | 1898 | Noida, Uttar Pradesh, India | USD 26.35 M | 1,192 | ||
Operates an online store specializing in ayurvedic and homeopathic medicines. | 2016 | Delhi, Delhi, India | USD 1.25 M | 16 | ||
Offers Ayurvedic treatments, consultations, and products for various diseases and wellness. | 1992 | Faridabad, Haryana, India | USD 10.08 M | 570 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fluence Pharma
Complete news archive for Fluence Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fluence Pharma
Fluence Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Fluence Pharma, Fluence Pharma Private Limited, reported revenue of βΉ37.55 Cr for FY 2025, up 4% year on year.
Fluence Pharma, based in Mumbai, focuses on providing healthcare solutions, producing pharmaceutical products, nutritional supplements, and personalized products. Develops and manufactures personalized nutritional supplements for health and wellness. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Fluence Pharma's top competitors include MyGlamm, Mamaearth and WOW Skin Science.
Fluence Pharma has 1 investor. Key investors include Honasa Consumer.
Fluence Pharma operates through Fluence Pharma Private Limited.
Yes. Fluence Pharma was acquired by Honasa Consumer in June 2026.
The legal entities of Fluence Pharma currently have 3 directors, including Ashokkumar Bhusari, Rajendrasingh Jalamsingh Rajput, Abhijit Paul.
